Feature|Articles|December 10, 2023
- Pharmaceutical Executive: December 2023
- Volume 43
- Issue 12
Pharmaceutical Executive: December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Finding that Sparkover 2 years ago
Remote Reliance: The Rise of Oncology Home Careover 2 years ago
It’s Always Important to Remember: Leaders Make Mistakesover 2 years ago
FDA, Industry Face Challenges in the Year Aheadover 2 years ago
Navigating the Future: Key Market Access Trends to Watch in ’24over 2 years ago
Reflecting on 2023Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5